Moving towards clinical trials for mitochondrial diseases.

Abstract excerpt

Primary mitochondrial diseases represent some of the most common and severe inherited metabolic disorders, affecting ~1 in 4,300 live births. The clinical and molecular diversity typified by mitochondrial diseases has contributed to the lack of licensed disease-modifying therapies available. Management for the majority of patients is primarily supportive. The failure of clinical trials in mitochondrial diseases...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Oxidative Phosphorylation
• Share to RNA, Transfer
• Share to Hypoxia